XOMA Royalty (XOMA) Current Assets (2010 - 2026)

XOMA Royalty's (XOMA) quarterly Current Assets came in at $118.7 million in Q1 2026, up 4.88% year-on-year from $113.2 million in Q1 2025, and up 1.27% quarter-over-quarter from $117.3 million in Q4 2025.

XOMA Royalty (XOMA) Current Assets (2010 - 2026) Analysis & Trends

XOMA Royalty has disclosed Current Assets across 17 years of filings, most recently posting $118.7 million for Q1 2026.

  • Current Assets for Q1 2026 came in at $118.7 million, up 4.88% year-over-year; the trailing twelve-month figure through Mar 2026 was $118.7 million (up 4.88% YoY), and the FY2025 annual result was $117.3 million, down 6.64% from the prior year.
  • Current Assets came in at $118.7 million for Q1 2026 at XOMA Royalty, up from $117.3 million in the prior quarter.
  • In the past five years, Current Assets ranged from a high of $169.3 million in Q4 2023 to a low of $34.5 million in Q3 2023.
  • The 5-year median for Current Assets is $110.7 million (2025), against an average of $103.8 million.
  • Across the five-year window, Current Assets plunged 56.73% in 2023 and soared 360.86% in 2024, its largest moves.
  • XOMA Royalty's Current Assets stood at $61.3 million in 2022, then surged by 176.42% to $169.3 million in 2023, then slipped by 25.82% to $125.6 million in 2024, then declined by 6.64% to $117.3 million in 2025, then gained by 1.27% to $118.7 million in 2026.
  • The last three Current Assets figures came in at $118.7 million (Q1 2026), $117.3 million (Q4 2025), and $110.7 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Current Assets (Qtr)
1 Alterity Therapeutics 788,338.31 Bn 788,338.28 Bn - 37.31 Mn
2 Belite Bio 56,560.00 Bn 56,560.00 Bn - 521.86 Mn
3 Quantum Biopharma 17,329.30 Bn 17,329.30 Bn - 10.37 Mn
4 Legend Biotech 3,341.00 Bn 3,340.71 Bn 242.10 Mn 1.25 Bn
5 Akari Therapeutics 1,727.91 Bn 1,727.91 Bn - 3.59 Mn
6 Evaxion A 1,536.68 Bn 1,536.67 Bn - -
7 Psyence Biomedical 238.34 Bn 238.33 Bn - 7.63 Mn
8 Vertex Pharmaceuticals 113.42 Bn 106.17 Bn 2.59 Bn 11.73 Bn
9 Abivax 95.45 Bn 95.45 Bn - 600.85 Mn
10 XOMA Royalty 5.52 Mn -60.56 Mn - 118.75 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 118.75 Mn
Dec 31, 2025 117.26 Mn
Sep 30, 2025 110.71 Mn
Jun 30, 2025 104.93 Mn
Mar 31, 2025 113.23 Mn
Dec 31, 2024 125.60 Mn
Sep 30, 2024 159.02 Mn
Jun 30, 2024 162.20 Mn
Mar 31, 2024 146.89 Mn
Dec 31, 2023 169.31 Mn
Sep 30, 2023 34.51 Mn
Jun 30, 2023 38.42 Mn
Mar 31, 2023 45.07 Mn
Dec 31, 2022 61.25 Mn
Sep 30, 2022 79.74 Mn
Jun 30, 2022 87.26 Mn
Mar 31, 2022 89.61 Mn
Dec 31, 2021 96.97 Mn
Sep 30, 2021 74.87 Mn
Jun 30, 2021 87.25 Mn